Sort
172,184 grants matching “inflammation”
Ancillary Study 1
$1,001,346Christopher Hooper Goss · University Of Washington · UM1 · FY2013 · HL
Microglial, Inflammatory and Omics Markers of Cerebral Small Vessel Disease in the CHARGE Consortium
$1,001,222Sudha Seshadri · Boston University Medical Campus · UH2 · FY2017 · NS
Cell-free assay technologies for the identification of active compounds
$1,001,166Barry Okeefe · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Parametric Response Mapping in COPD
$1,001,078Meilan K Han · University Of Michigan At Ann Arbor · R01 · FY2016 · HL
Exisulind for Chemoprevention of Lung Cancer
$1,000,956Md, Jhanelle Gray · H. Lee Moffitt Cancer Ctr & Res Inst · U01 · FY2007 · CA
An all-optical electrophysiology platform for the discovery of pain therapeutics
$1,000,946Owen B. McManus · Q-State Biosciences, Inc. · R44 · FY2020 · NS
Age-Related Macular Degeneration: Genetic Variations and Animal Model
$1,000,820Chi-Chao Chan · National Eye Institute · ZIA · FY2012 · EY
Endothelial Dysfunction, Biomarkers and Lung Function
$1,000,726Columbia University Health Sciences · R01 · FY2004 · HL
PULMONARY EFFECTS OF ENVIROMENTAL OXIDANT POLLUTANTS
$1,000,700University Of California Davis · P01 · FY2002 · ES
IL-13, MYOFIBROBLASTS &ELASTIC RECOIL IN SEVERE ASTHMA
$1,000,684National Jewish Health · R01 · FY2003 · HL
Asthma and Allergic Disease Center
$1,000,636Thomas A. Platts-Mills · University Of Virginia · U19 · FY2009 · AI
Completion of IND-enabling studies required for first-in-human studies of a novel oral therapeutic agent for treating pulmonary fibrosis
$1,000,618James Craig Hartman · Mdi Therapeutics, Inc. · R44 · FY2022 · HL
Integrative And Molecular Studies Of Pain And Pain Control
$1,000,542Michael J. Iadarola · National Institute Of Dental & Craniofacial Research · ZIA · FY2009 · DE
TGF-beta Regulation of Mucosal and Systemic T Cell Immunity and Tolerance
$1,000,260Wanjun Chen · Dental & Craniofacial Research · Z01 · FY2007 · DE
Macrophage Polarization in Response to Infections and Inflammation
$1,000,214Pradipta Ghosh · University Of California, San Diego · R01 · FY2020 · AI
A Laser Microbeam Biotechnology Resource
$1,000,131Anthony J Durkin · University Of California-Irvine · P41 · FY2017 · EB
Inflammation, Viral Replication, and Atherosclerosis in Treated HIV Infection
$1,000,114Priscilla Y. Hsue · University Of California, San Francisco · R01 · FY2011 · HL
Development of novel immunotherapy for influenza virus infection
$1,000,001Kazue Takahashi · Massachusetts General Hospital · U01 · FY2007 · AI
Development of anti-sense oligonucleotides as a therapeutic for cancer pain through selective block of sodium channel pain targets
$1,000,001Hongkang Zhang · Quiver Bioscience Inc. · R44 · FY2021 · CA
Nebulized ALX1 as a treatment for Pseudomonas aeruginosa infections in bronchiectasis patients
$1,000,000Nathan Allan Stasko · Vast Therapeutics, Inc. · R44 · FY2025 · AI
Development of a dry powder inhalation product against Respiratory Syncytial Virus based on an endogenous anionic pulmonary surfactant lipid
$1,000,000Ajay Gupta · Celestial Therapeutics Inc. · R44 · FY2025 · AI
IND enabling development of LGM2605 as adjuvant treatment for asthma
$1,000,000Thais Motria Sielecki · Lignamed, Llc · R42 · FY2019 · AI
Clinical Development of a Therapeutic Agent for COPD
$1,000,000Indu Parikh · Biomarck Pharmaceuticals, Ltd · R44 · FY2015 · HL
Treatment of Inflammatory Complications of Respiratory Infection
$1,000,000Michael William Lark · Respana Therapeutics, Inc. · R42 · FY2024 · AI
A Novel Immunologically Enhanced Probiotic for Treating Rheumatoid Arthritis
$1,000,000Gary Fanger · Rise Therapeutics, Llc · R44 · FY2021 · AI